Using Robotics in the ATMP Space
The use of robotics to manufacture Advanced Therapy and Medicinal Products (ATMP) solves many challenges, including significantly limiting exposure to human generated contamination. There are steps to mitigate contamination points but with the strong endorsements recently made within the current revision to Annex 1 encouraging the use of robotics (Section 8.9),1 eliminating human interventions should be considered seriously.
- 1European Commission. (August 2022) The Rules Governing Medicinal Products in the European Union Volume 4 EU Guidelines for Good Manufacturing Practice for Medicinal Products for Human and Veterinary Use. Retrieved from https://health.ec.europa.eu/system/files/2022- 08/20220825_gmp-an1_en_0.pdf